Skip to main content
. 2024 Mar 14;11:1295026. doi: 10.3389/fnut.2024.1295026

Figure 1.

Figure 1

Signs and symptoms in the follow-up assessment. Data are presented as the percentage of patients in the group. (A) Loss of Smell; (B) Loss of Taste; (C) Loss of Appetite; (D) Headache; (E) Depression; (F) Hearing Loss. Comparisons were performed using the Chi-squared test. SR, Self-Reported Symptoms group; SRPF, Self-Reported Symptoms and decreased Pulmonary Function group.